144 related articles for article (PubMed ID: 19414341)
1. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
2. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
[TBL] [Abstract][Full Text] [Related]
3. Expression of nuclear receptors and cofactors in human endometrium and myometrium.
Vienonen A; Miettinen S; Bläuer M; Martikainen PM; Tomás E; Heinonen PK; Ylikomi T
J Soc Gynecol Investig; 2004 Feb; 11(2):104-12. PubMed ID: 14980312
[TBL] [Abstract][Full Text] [Related]
4. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
5. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
Hussein-Fikret S; Fuller PJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
[TBL] [Abstract][Full Text] [Related]
6. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
7. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium.
Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Uchikawa J; Itoh K; Konishi I
J Clin Endocrinol Metab; 2003 Feb; 88(2):871-8. PubMed ID: 12574227
[TBL] [Abstract][Full Text] [Related]
8. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
10. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
[TBL] [Abstract][Full Text] [Related]
11. Sexual dimorphism in the content of progesterone and estrogen receptors, and their cofactors in the lung of adult rats.
González-Arenas A; Neri-Gómez T; Guerra-Araiza C; Camacho-Arroyo I
Steroids; 2004 May; 69(5):351-6. PubMed ID: 15219413
[TBL] [Abstract][Full Text] [Related]
12. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.
Leong GM; Subramaniam N; Issa LL; Barry JB; Kino T; Driggers PH; Hayman MJ; Eisman JA; Gardiner EM
Biochem Biophys Res Commun; 2004 Mar; 315(4):1070-6. PubMed ID: 14985122
[TBL] [Abstract][Full Text] [Related]
13. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
[TBL] [Abstract][Full Text] [Related]
14. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
15. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the content of progesterone and estrogen receptors, and their cofactors SRC-1 and SMRT by the 26S proteasome in the rat brain during the estrous cycle.
Villamar-Cruz O; Manjarrez-Marmolejo J; Alvarado R; Camacho-Arroyo I
Brain Res Bull; 2006 Apr; 69(3):276-81. PubMed ID: 16564422
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex.
Jayne S; Zwartjes CG; van Schaik FM; Timmers HT
Biochem J; 2006 Sep; 398(3):461-7. PubMed ID: 16712523
[TBL] [Abstract][Full Text] [Related]
19. Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer.
Pathirage N; Di Nezza LA; Salmonsen LA; Jobling T; Simpson ER; Clyne CD
Fertil Steril; 2006 Aug; 86(2):469-72. PubMed ID: 16730717
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia.
Amezcua CA; Zheng W; Muderspach LI; Felix JC
Gynecol Oncol; 1999 Apr; 73(1):126-36. PubMed ID: 10094893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]